The drug Topamax, commonly used for treating seizures associated with epilepsy and preventing serious migraines, may also raise the risk of oral birth defects during pregnancy. Oral birth defects that can be triggered by the use of Topamax include cleft lip and cleft palate. This news comes after the Food and Drug Administration released a new warning regarding the highly popular drug.
Increased Warning on Topamax Label
As data from studies shows the possible correlation between Topamax and cleft lip, the FDA states that there will be a stronger label on the product. The pregnancy category of the drug has been changed. The warning will now show Topamax in category D, as opposed to its former spot in category C. There has been positive evidence of fetal risk in human beings, which is the reason for the change of category.
During the first trimester of pregnancy, if the lip or palate fails to fuse together, cleft lip or cleft palate defects may occur. The degree and seriousness of the defect can widely vary. Defects can be as minimal as simply a small notch in the lip, to a more dramatic occurrence of a groove that spans the roof of the mouth and nose. More serious cleft lip issues may lead to problems with speech, eating, and the possibility of ear infections.
Cleft Lip Lawyers in New Jersey and Philadelphia
If you were recently pregnant and your child has had a birth defect, it is possible that you may have some questions. Please contact the Mininno Law Office for any questions regarding cleft lip, Topamax use during pregnancy, or call for a free consultation at (856) 833-0600 in New Jersey, or (215) 567-2380 in Philadelphia.